Photonic Pharma

company

About

Photonic Pharma is an early phase of drug development

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$499.44K
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Photonic Pharma is an early phase of drug development which uses a game-changing technology platform that combines breakthroughs in fluorescence biosensor engineering and fluorescence lifetime detection in living cells.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.09M
Photonic Pharma has raised a total of $1.09M in funding over 2 rounds. Their latest funding was raised on Jan 15, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 15, 2021 Grant $499.44K 1 Detail
Sep 15, 2019 Grant $593.88K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Photonic Pharma is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant